Exelon (NASDAQ:EXC – Free Report) had its target price cut by Barclays from $44.00 to $42.00 in a research report released on Wednesday morning,Benzinga reports. They currently have an overweight rating on the stock.
A number of other equities research analysts have also recently commented on the company. Evercore ISI upgraded Exelon from an “in-line” rating to an “outperform” rating and raised their target price for the company from $43.00 to $44.00 in a research report on Tuesday. Scotiabank boosted their price target on shares of Exelon from $40.00 to $42.00 and gave the stock a “sector perform” rating in a report on Thursday, December 12th. Finally, Morgan Stanley decreased their price objective on shares of Exelon from $46.00 to $44.00 and set an “equal weight” rating on the stock in a report on Friday, November 22nd. Five analysts have rated the stock with a hold rating and four have issued a buy rating to the company. According to MarketBeat.com, Exelon presently has a consensus rating of “Hold” and a consensus price target of $43.13.
Check Out Our Latest Stock Report on Exelon
Exelon Stock Down 3.0 %
Exelon (NASDAQ:EXC – Get Free Report) last announced its quarterly earnings results on Wednesday, October 30th. The company reported $0.71 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.67 by $0.04. The company had revenue of $6.15 billion during the quarter, compared to the consensus estimate of $5.85 billion. Exelon had a return on equity of 9.47% and a net margin of 10.60%. Exelon’s revenue for the quarter was up 2.9% on a year-over-year basis. During the same period in the previous year, the company posted $0.67 earnings per share. As a group, equities research analysts forecast that Exelon will post 2.46 earnings per share for the current year.
Exelon Dividend Announcement
The firm also recently announced a quarterly dividend, which was paid on Friday, December 13th. Shareholders of record on Monday, November 11th were paid a dividend of $0.38 per share. The ex-dividend date of this dividend was Friday, November 8th. This represents a $1.52 annualized dividend and a yield of 3.88%. Exelon’s dividend payout ratio (DPR) is 62.55%.
Hedge Funds Weigh In On Exelon
Hedge funds have recently modified their holdings of the business. JPMorgan Chase & Co. lifted its stake in Exelon by 109.0% during the 3rd quarter. JPMorgan Chase & Co. now owns 5,884,282 shares of the company’s stock worth $238,608,000 after acquiring an additional 3,068,309 shares in the last quarter. State Street Corp boosted its position in Exelon by 3.7% in the 3rd quarter. State Street Corp now owns 60,169,219 shares of the company’s stock valued at $2,439,862,000 after buying an additional 2,156,259 shares during the period. Nordea Investment Management AB increased its position in shares of Exelon by 418.1% during the fourth quarter. Nordea Investment Management AB now owns 2,501,392 shares of the company’s stock worth $94,152,000 after acquiring an additional 2,018,604 shares during the period. FMR LLC boosted its holdings in Exelon by 18.7% in the third quarter. FMR LLC now owns 11,782,549 shares of the company’s stock valued at $477,782,000 after purchasing an additional 1,858,502 shares during the period. Finally, Assenagon Asset Management S.A. grew its stake in Exelon by 212.2% during the 4th quarter. Assenagon Asset Management S.A. now owns 1,903,482 shares of the company’s stock worth $71,647,000 after purchasing an additional 1,293,753 shares in the last quarter. 80.92% of the stock is currently owned by hedge funds and other institutional investors.
About Exelon
Exelon Corporation, a utility services holding company, engages in the energy distribution and transmission businesses in the United States and Canada. The company is involved in the purchase and regulated retail sale of electricity and natural gas, transmission and distribution of electricity, and distribution of natural gas to retail customers.
Further Reading
- Five stocks we like better than Exelon
- ETF Screener: Uses and Step-by-Step Guide
- Oracle Announces Game-Changing News for the AI Industry
- Market Cap Calculator: How to Calculate Market Cap
- Netflix Adds 19 Million Subscribers, Growth Is Far From Over
- The Basics of Support and Resistance
- Tempus AI: A Game-Changer in AI-Powered Healthcare
Receive News & Ratings for Exelon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exelon and related companies with MarketBeat.com's FREE daily email newsletter.